List view / Grid view
22 May 2015 | By Victoria White
Novartis has announced positive results from two pivotal Phase III clinical trial programmes for QVA149 and NVA237 in patients with moderate-to-severe COPD...
22 May 2015 | By Victoria White
Nabriva has announced the appointment of Elyse Seltzer, MD, as Chief Medical Officer. Dr Seltzer assumes the role from Dr William Prince...
21 May 2015 | By Victoria White
Data presented from the Clostridium difficile Infection (CDI) Service Evaluation study shows that the adoption pattern of treatment impacts CDI outcomes...
21 May 2015 | By Victoria White
The FDA has granted Orphan Drug Designation to Alnylam’s revusiran for the treatment of transthyretin (TTR)-mediated amyloidosis (ATTR amyloidosis)...
21 May 2015 | By CBR International
CBR International’s Scientific Experts Supporting Mapp Biopharmaceutical Pertaining to ZMAPPTM...
21 May 2015 | By Victoria White
Phase 3 study of sarilumab met its co-primary efficacy endpoints of a greater improvement in signs and symptoms of rheumatoid arthritis...
21 May 2015 | By Victoria White
Despite optimism surrounding new dengue and a malaria vaccines, vaccination alone is not a long-term solution for combatting these diseases, says GlobalData...
21 May 2015 | By Victoria White
New data shows tiotropium/olodaterol Respimat provides lung function benefit to patients with COPD from the start of maintenance therapy...
20 May 2015 | By Victoria White
Genocea Biosciences has announced positive top-line data from a Phase 2 dose optimisation trial evaluating GEN-003 for the treatment of genital herpes...
20 May 2015 | By Victoria White
The Society of Occupational Medicine has published new standards of care that, if followed, could prevent future cases of COPD...
20 May 2015 | By Victoria White
Astellas Pharma EMEA, a pharmaceutical company dedicated to improving the health of people around the world, is celebrating its 10th anniversary...
20 May 2015 | By Victoria White
Driven by reforms and private investments, Turkey is steadily emerging as one of the hottest healthcare markets in the global arena...
20 May 2015 | By Victoria White
To mark International Clinical Trials Day 2015, the National Institute for Health Research (NIHR) has launched a new Clinical Trials Guide for Trainees.
20 May 2015 | By Victoria White
The FDA have approved Janssen’s New Drug Application (NDA) for the three-month long-acting atypical antipsychotic Invega Trinza...
20 May 2015 | By Victoria White
The global treatment market for dyslipidemia will more than double from $15.4 billion in 2013 to an estimated $37.9 billion by 2023, according to GlobalData...
